4586 メドレックス 企業サイト Yahooファイナンス 日経新聞 株探
基本データ
【業種】医薬品【市場】グロース（内国株式）
【決算期】12月
【会社設立】2002.1
【上場】2013.2
【直近決算日】2024-05-10
【決算予定日】
【時価総額】56億2500万円
【予想PER】 倍
【PBR】3.03 倍
【自己資本比率】92.9 %
業績予想（通期のみ）
| 年度 | タイプ | 日付 | 売上高 | 営業利益 | 経常利益 | 純利益 |
|---|---|---|---|---|---|---|
| 2022-12 | 新規 | 2022-02-10 | 289 | -1002 | -1003 | -1006 |
| 修正 | 2022-11-11 | 359(↑) | -881(↑) | -900(↑) | -899(↑) | |
| 修正 | 2022-12-27 | 59(↓) | -1181(↓) | -1200(↓) | -1199(↓) | |
| 2023-12 | 新規 | 2023-02-10 | 127 | -830 | -783 | -786 |
| 修正 | 2023-09-15 | 127(→) | -950(↓) | -903(↓) | -906(↓) | |
| 修正 | 2023-09-29 | 27(↓) | -1050(↓) | -1003(↓) | -1006(↓) | |
| 2024-12 | 新規 | 2024-02-09 | 200 | -1425 | -1384 | -1386 |
| 修正 | 2024-04-24 | 442(↑) | -1183(↑) | -1142(↑) | -1144(↑) |
| 決算期 | 四半期 | 売上高 | 営業利益 | 経常利益 | 純利益 | 営業利益率 | 経常利益率 | 売上高/前年比 | 営業利益/前年比 | 経常利益/前年比 | 純利益/前年比 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 予想 | 442 | -1183 | -1142 | -1144 | ― | ― | ― | ― | ― | ― | |
| 2024-12 | 1 | -176 | -127 | -128 | ― | ― | -100% | ― | ― | ― | |
| 2023-12 | 4 | 29 | -933 | -930 | -932 | -3217.24% | -3206.9% | -50.3% | ― | ― | ― |
| 3 | 29 | -670 | -668 | -671 | -2310.34% | -2303.45% | 208.8% | ― | ― | ― | |
| 2 | 6 | -478 | -480 | -481 | -7966.67% | -8000% | -26.6% | ― | ― | ― | |
| 1 | 6 | -294 | -289 | -290 | -4900% | -4816.67% | 253.1% | ― | ― | ― | |
| 2022-12 | 4 | 59 | -1098 | -1112 | -1111 | -1861.02% | -1884.75% | 612.4% | ― | ― | ― |
| 3 | 9 | -621 | -636 | -635 | -6900% | -7066.67% | 14% | ― | ― | ― | |
| 2 | 9 | -374 | -382 | -381 | -4155.56% | -4244.44% | 26.7% | ― | ― | ― | |
| 1 | 1 | -189 | -198 | -196 | -18900% | -19800% | -73.7% | ― | ― | ― | |
| 2021-12 | 4 | 8 | -1061 | -1074 | -1059 | -13262.5% | -13425% | -92.7% | ― | ― | ― |
| 3 | 8 | -675 | -688 | -677 | -8437.5% | -8600% | -44.9% | ― | ― | ― | |
| 2 | 7 | -471 | -483 | -473 | -6728.57% | -6900% | -50.4% | ― | ― | ― | |
| 1 | 7 | -262 | -264 | -262 | -3742.86% | -3771.43% | ― | ― | ― | ― | |
| 2020-12 | 4 | 115 | -1130 | -1152 | -1114 | -982.61% | -1001.74% | -32.2% | ― | ― | ― |
| 3 | 15 | -958 | -978 | -981 | -6386.67% | -6520% | -91% | ― | ― | ― | |
| 2 | 15 | -706 | -713 | -713 | -4706.67% | -4753.33% | -47.7% | ― | ― | ― | |
| 1 | -305 | -307 | -302 | ― | ― | ― | ― | ― | ― | ||
| 2019-12 | 4 | 169 | -1627 | -1633 | -1616 | -962.72% | -966.27% | 1922.9% | ― | ― | ― |
| 3 | 168 | -1209 | -1215 | -1196 | -719.64% | -723.21% | 1903.4% | ― | ― | ― | |
| 2 | 28 | -877 | -884 | -867 | -3132.14% | -3157.14% | 343.9% | ― | ― | ― | |
| 1 | 18 | -479 | -484 | -467 | -2661.11% | -2688.89% | ― | ― | ― | ― | |
| 2018-12 | 4 | 8 | -1273 | -1285 | -1267 | -15912.5% | -16062.5% | -95.8% | ― | ― | ― |
| 3 | 8 | -947 | -958 | -940 | -11837.5% | -11975% | -57.1% | ― | ― | ― | |
| 2 | 8 | -575 | -588 | -572 | -7187.5% | -7350% | -55.56% | ― | ― | ― | |
| 1 | 0 | -298 | -310 | -292 | 0% | 0% | ― | ― | ― | ― | |
| 2017-12 | 4 | 198 | -983 | -988 | -884 | -496.46% | -498.99% | 800% | ― | ― | ― |